But Who's Gonna Pay For It? | GenomeWeb

One of the biggest stumbling blocks facing pharmacogenomics is getting insurance companies to realize the value of genetic testing and agree to foot the bill. That challenge is at the heart of this article from the San Jose Mercury News.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.